Clinical Trials

Fallopian Tube Neoplasms

NCT05659381 2026-04-16

HOTT

Phase 3 Recruiting

220 enrolled

Phase NA Not yet recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07530679 2026-04-15

Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination

360 enrolled

Cervical Cancer Prevention

NCT01164150 2026-04-13

Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06

Phase 2 Terminated

92 enrolled

Phase 2 Active not recruiting

Radiation Injuries, Endometrial Neoplasms

NCT01244789 2026-04-13

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

244 enrolled

Endometrial Neoplasms

NCT03939481 2026-04-13

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

Active not recruiting

1,336 enrolled

GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms

NCT06274541 2026-04-13

Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study

200 enrolled

Fallopian Tube Neoplasms

NCT05510908 2026-03-25

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

GastrointestinalGynecologicLymphoidSarcoma

460 enrolled 7 charts

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Anus Neoplasms, Uterine Cervical Neoplasms, Lymphoma, Neoplasms, Sarcoma, Kaposi, HIV Infections, Lymphoma, AIDS-Related

NCT04393285 2026-03-09

Abemaciclib and Letrozole to Treat Endometrial Cancer

Phase 2 Active not recruiting

53 enrolled

Endometrial Neoplasms

NCT07397715 2026-02-12

MUSA3

Recruiting

1,000 enrolled

Phase 2 Active not recruiting

Uterine Anomalies, Dysmenorrhea, Dyspareunia, Infertility, Menorrhagia, Metrorrhagia, Myoma, Abdominal Pain, Adenomyoma, Hemostatic Disorders, Adenomyosis

NCT03480776 2026-01-14

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

117 enrolled

Ovarian Cancer Prevention

NCT02829437 2026-01-02

EST

Recruiting

100 enrolled

Endometrial Stromal Tumors

NCT00980954 2025-12-31

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

236 enrolled 28 charts

Uterine Cervical Neoplasms

NCT04111978 2025-09-29

MATAO

Phase 3 Recruiting

540 enrolled

Fallopian Tube Neoplasms, Peritoneal Neoplasms

NCT02059499 2025-07-23

Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions

91 enrolled 26 charts

Squamous Intraepithelial Lesions, HIV Infections

NCT01101451 2025-05-23

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

340 enrolled 13 charts

Uterine Cervical Neoplasms

NCT04831580 2024-12-19

ROCC

Phase NA Recruiting

840 enrolled

Uterine Cervical Neoplasms

NCT01658930 2024-12-17

SHAPE

Phase NA Completed

700 enrolled 12 charts

Uterine Cervical Neoplasms

NCT02228681 2024-09-19

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

74 enrolled 13 charts

Advanced, Persistent, or Recurrent Endometrial Cancer

NCT01445275 2024-08-21

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Withdrawn

BreastGynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT01164735 2024-08-14

Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

169 enrolled

Recurrent Uterine Corpus Carcinoma

NCT01198171 2024-08-14

Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer

243 enrolled

Stage I Uterine Corpus Cancer

NCT01344837 2024-08-14

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

360 enrolled

Endometrial Serous Adenocarcinoma

NCT02135419 2024-07-26

ANCHOR

GastrointestinalGynecologic

4,446 enrolled 13 charts

Squamous Intraepithelial Lesions, Acquired Immunodeficiency Syndrome, Anus Neoplasms, HIV Infections, Papillomavirus Infections

NCT01941316 2024-05-09

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Phase 1/2 Completed

78 enrolled 15 charts

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT00892866 2024-05-03

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

Phase NA Active not recruiting

877 enrolled

GynecologicOther neoplasm

Uterine Cervical Dysplasia, Endometrial Hyperplasia, Papillomavirus Infections

NCT00667563 2024-03-19

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

Phase 1 Completed

150 enrolled 12 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions, HIV Infections, Papillomavirus Infections

NCT01402271 2023-12-11

Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Phase 1/2 Completed

88 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03412630 2023-11-24

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Phase NA Terminated

1 enrolled 1 chart

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00513526 2023-11-14

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

GynecologicOther neoplasm

112 enrolled 16 charts

Squamous Intraepithelial Lesions, Infections, Precancerous Conditions, Atypical Squamous Cells of the Cervix

NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

131 enrolled 18 charts 1 FDA

CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

NCT01506856 2023-09-15

iPocc

Phase 2/3 Completed

655 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00993655 2023-08-28

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

275 enrolled 13 charts

GynecologicThoracic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pleural Effusion, Malignant

NCT00053794 2023-08-04

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

BreastGenitourinaryGynecologicThoracic

17 enrolled

GynecologicSarcoma

Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00471432 2023-08-04

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Phase 1 Completed

40 enrolled

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male

NCT00770185 2023-08-04

Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer

35 enrolled

Endometrial Neoplasms

NCT02459301 2023-08-04

A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies

Phase 1 Completed

59 enrolled

Gynecologic Cancer

NCT00003308 2023-06-22

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

CNSDermatologicGenitourinaryGynecologicSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Chondrosarcoma, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00003518 2023-06-22

Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

44 enrolled

GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms

NCT00499291 2023-05-25

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Phase NA Withdrawn

Teratoma, Testicular, Teratoma, Ovarian, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Teratoma, Testicular Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma

NCT00492778 2023-03-29

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Phase 2 Unknown

165 enrolled 15 charts

Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation

NCT02659384 2023-03-14

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

122 enrolled

Ovarian Neoplasms

NCT01414608 2022-11-07

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer

926 enrolled 13 charts